These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 28033265

  • 1. An atypical sarcoidosis involvement in FDG PET/CT: A case report.
    Robin P, Benigni P, Feger B, Salaun PY, Abgral R.
    Medicine (Baltimore); 2016 Dec; 95(52):e5700. PubMed ID: 28033265
    [Abstract] [Full Text] [Related]

  • 2. Laryngeal sarcoidosis detected by FDG positron emission tomography.
    Kaira K, Ishizuka T, Yanagitani N, Sunaga N, Hisada T, Mori M.
    Clin Nucl Med; 2008 Dec; 33(12):878-9. PubMed ID: 19033796
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pancreatic involvement detected with (18)F-FDG PET/CT in disseminated sarcoidosis.
    Delgado-Bolton RC, Arias Navalón JA, Rodríguez Alfonso B, Delgado-Bolton AN, Pérez-Castejón MJ, Sánchez-Escribano R, Cabrera Martín MN, Lapeña Gutiérrez L, Carreras Delgado JL.
    Rev Esp Med Nucl; 2011 Dec; 30(1):29-32. PubMed ID: 20638156
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
    Braun JJ, Kessler R, Constantinesco A, Imperiale A.
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1537-43. PubMed ID: 18418595
    [Abstract] [Full Text] [Related]

  • 7. The scar sign: a useful finding on FDG PET/CT to distinguish sarcoidosis from other causes of lymphadenopathy.
    Lu SJ, Lee VK, Loo SW.
    Clin Nucl Med; 2013 Mar; 38(3):205-8. PubMed ID: 23354040
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
    Kaira K, Oriuchi N, Otani Y, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Endo K, Mori M.
    Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
    [Abstract] [Full Text] [Related]

  • 14. Dual Time-Point 18F-FDG PET/CT in Spinal Sarcoidosis: A Single Institution Case Series.
    Ordóñez-Rubiano EG, Solano-Noguera DF, Row W, Weinberg J, Tatsui CE, Johnson JM, Gule-Monroe MK.
    Spine (Phila Pa 1976); 2019 Nov 01; 44(21):E1248-E1255. PubMed ID: 31634300
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monitoring the Therapy of Extensive Osseous Sarcoidosis With FDG PET/CT.
    Yang H, Numani S, Liu S.
    Clin Nucl Med; 2017 Jul 01; 42(7):e337-e339. PubMed ID: 28240658
    [Abstract] [Full Text] [Related]

  • 18. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
    Iino M, Iizuka C.
    Rinsho Ketsueki; 2012 May 01; 53(5):540-2. PubMed ID: 22728558
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.